N. Miller

902 total citations · 1 hit paper
33 papers, 562 citations indexed

About

N. Miller is a scholar working on Molecular Biology, Genetics and Psychiatry and Mental health. According to data from OpenAlex, N. Miller has authored 33 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Genetics and 7 papers in Psychiatry and Mental health. Recurrent topics in N. Miller's work include Muscle Physiology and Disorders (19 papers), Neurogenetic and Muscular Disorders Research (14 papers) and Cerebral Palsy and Movement Disorders (7 papers). N. Miller is often cited by papers focused on Muscle Physiology and Disorders (19 papers), Neurogenetic and Muscular Disorders Research (14 papers) and Cerebral Palsy and Movement Disorders (7 papers). N. Miller collaborates with scholars based in United States and France. N. Miller's co-authors include Linda Lowes, Lindsay N. Alfano, M. Iammarino, Jerry R. Mendell, Samiah Al-Zaidy, Kathleen Church, Zarife Sahenk, Louise R. Rodino‐Klapac, Sarah Lewis and Mark Hogan and has published in prestigious journals such as Neurology, PEDIATRICS and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

N. Miller

26 papers receiving 553 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy

2020 264 citations Jerry R. Mendell, Zarife Sahenk et al. JAMA Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Miller United States	8	447	189	171	99	97	33	562
Rachael A. Potter United States	11	581 1.3×	129 0.7×	272 1.6×	153 1.5×	61 0.6×	30	667
Annarita Armaroli Italy	9	354 0.8×	74 0.4×	62 0.4×	90 0.9×	77 0.8×	16	474
Lauren P. Morgenroth United States	10	498 1.1×	106 0.6×	93 0.5×	189 1.9×	42 0.4×	15	587
Mike Pike United Kingdom	8	472 1.1×	119 0.6×	57 0.3×	85 0.9×	97 1.0×	12	692
Kelly J. Lehman United States	13	791 1.8×	457 2.4×	387 2.3×	164 1.7×	265 2.7×	37	1.1k
Jessica C. de Greef Netherlands	15	897 2.0×	205 1.1×	130 0.8×	174 1.8×	76 0.8×	30	998
Susana Quijano‐Roy France	13	275 0.6×	199 1.1×	58 0.3×	45 0.5×	137 1.4×	32	466
Heike Kölbel Germany	14	444 1.0×	461 2.4×	84 0.5×	46 0.5×	314 3.2×	56	722
Markus McColly United States	5	269 0.6×	250 1.3×	87 0.5×	29 0.3×	165 1.7×	12	408
Carlos de Sousa United Kingdom	14	231 0.5×	94 0.5×	91 0.5×	40 0.4×	87 0.9×	21	629

Countries citing papers authored by N. Miller

Since Specialization

Citations

This map shows the geographic impact of N. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Miller more than expected).

Fields of papers citing papers by N. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Miller. The network helps show where N. Miller may publish in the future.

Co-authorship network of co-authors of N. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of N. Miller. A scholar is included among the top collaborators of N. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Miller. N. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, N., et al.. (2025). Intertrochanteric Fractures in the Elderly Treated with Different Intramedullary Devices. JBJS Reviews. 13(3). 1 indexed citations

Bashir, Mohammed, et al.. (2024). Quantitative pupillometry as a potential biomarker in early concussion assessment. Journal of Clinical Neuroscience. 132. 111003–111003. 1 indexed citations

Schwartz, Carolyn E., et al.. (2023). Toward patient-centered treatment goals for duchenne muscular dystrophy: insights from the “Your Voice” study. Orphanet Journal of Rare Diseases. 18(1). 90–90. 3 indexed citations

Richardson, James W., Louise R. Rodino‐Klapac, Eric R. Pozsgai, et al.. (2022). 260 Gene transfer with rAAVrh74.MHCK7.SGCB increased β-sarcoglycan expression in LGMD type 2E patients. Journal of Neurology Neurosurgery & Psychiatry. 93(6). A88.3–A88.

Mendell, Jerry R., Perry B. Shieh, Zarife Sahenk, et al.. (2021). A Multicenter Randomized, Double-Blind, Placebo-Controlled, Gene-Delivery Clinical Trial of rAAVrh74.MHCK7.micro-dystrophin for Duchenne Muscular Dystrophy (4478). Neurology. 96(15_supplement). 2 indexed citations

Miller, N., Lindsay N. Alfano, M. Iammarino, et al.. (2020). Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatric Neurology. 113. 15–20. 18 indexed citations

Mah, May Ling, Linda Cripe, Samiah Al-Zaidy, et al.. (2020). Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing. International Journal of Cardiology. 316. 257–265. 14 indexed citations

Mendell, Jerry R., Zarife Sahenk, Kelly J. Lehman, et al.. (2020). Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy. JAMA Neurology. 77(9). 1122–1122. 264 indexed citations breakdown →

Lowes, Linda, et al.. (2019). Activity monitoring in neuromuscular disease: Successes, challenges, and a path forward (P5.6-016). Neurology. 92(15_supplement). 1 indexed citations

10.

Mendell, J., Richard Shell, Kelly J. Lehman, et al.. (2019). P.351Gene-replacement therapy (GRT) in spinal muscular atrophy type 1 (SMA1): long-term follow-up from the onasemnogene abeparvovec phase 1/2a clinical trial. Neuromuscular Disorders. 29. S184–S184. 1 indexed citations

11.

Alfano, Lindsay N., N. Miller, M. Iammarino, et al.. (2019). P.192The 100 meter timed test: responsiveness to change, predicting loss of ambulation, and data-driven phenotypes. Neuromuscular Disorders. 29. S105–S105. 1 indexed citations

12.

Alfano, Lindsay N., N. Miller, M. Iammarino, et al.. (2019). Clinically meaningful change on the 100 meter timed test in neuromuscular diseases (S33.003). Neurology. 92(15_supplement).

13.

Alfano, Lindsay N., N. Miller, M. Iammarino, et al.. (2019). ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Developmental Medicine & Child Neurology. 62(3). 303–309. 9 indexed citations

14.

Mendell, Jerry R., Richard Shell, Kelly J. Lehman, et al.. (2019). Gene-replacement therapy (GRT) in spinal muscular atrophy type 1 (SMA1): Long-term follow-up from the onasemnogene abeparvovec phase 1/2A clinical trial. Journal of the Neurological Sciences. 405. 271–271. 4 indexed citations

15.

Miller, N., Lindsay N. Alfano, M. Iammarino, et al.. (2019). Early signs of gross motor delay in very young boys with Duchenne muscular dystrophy (P1.6-068). Neurology. 92(15_supplement). 1 indexed citations

16.

Mendell, Jerry R., Louis G. Chicoine, Samiah Al-Zaidy, et al.. (2019). Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Human Gene Therapy. 30(7). 794–801. 37 indexed citations

17.

Rodino‐Klapac, Louise R., Eric R. Pozsgai, Sarah Lewis, et al.. (2019). Systemic Gene Transfer with rAAVrh74.MHCK7.SGCB Increased -sarcoglycan Expression in Patients with Limb Girdle Muscular Dystrophy Type 2E. Neuropediatrics.

18.

Miller, N., Lindsay N. Alfano, M. Iammarino, et al.. (2018). DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY. Neuromuscular Disorders. 28. S123–S123. 1 indexed citations

19.

Alfano, Lindsay N., N. Miller, Katherine Berry, et al.. (2017). The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscular Disorders. 27(5). 452–457. 20 indexed citations

20.

Mendell, Jerry R., Zarife Sahenk, Samiah Al-Zaidy, et al.. (2017). Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Molecular Therapy. 25(4). 870–879. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact